Clinical Trial Update: QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating QL1706 in combination with chemotherapy for recurrent or metastatic endometrial cancer; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• QL1706

Snippet

Sponsor: xiang yang | Conditions: Recurrent or Metastatic Endometrial Cancer | Phase 2 | Status: NOT_YET_RECRUITING